• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

末端补体复合物同源蛋白的系统发育分析支持C6和C7先出现,随后是C8和C9。

Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.

作者信息

Mondragón-Palomino M, Piñero D, Nicholson-Weller A, Laclette J P

机构信息

Department of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, A.P. 70228, 04510 México, D.F., México.

出版信息

J Mol Evol. 1999 Aug;49(2):282-9. doi: 10.1007/pl00006550.

DOI:10.1007/pl00006550
PMID:10441679
Abstract

The plasma complement system comprises several activation pathways that share a common terminal route involving the assembly of the terminal complement complex (TCC), formed by C5b-C9. The order of emergence of the homologous components of TCC (C6, C7, C8alpha, C8beta, and C9) has been determined by phylogenetic analyses of their amino acid sequences. Using all the sequence data available for C6-C9 proteins, as well as for perforins, the results suggested that these TCC components originated from a single ancestral gene and that C6 and C7 were the earliest to emerge. Our evidence supports the notion that the ancestral gene had a complex modular composition. A series of gene duplications in combination with a tendency to lose modules resulted in successive complement proteins with decreasing modular complexity. C9 and perforin apparently are the result of different selective conditions to acquire pore-forming function. Thus C9 and perforin are examples of evolutionary parallelism.

摘要

血浆补体系统由几种激活途径组成,这些途径共享一条共同的末端途径,该途径涉及由C5b - C9形成的末端补体复合物(TCC)的组装。通过对TCC同源成分(C6、C7、C8α、C8β和C9)的氨基酸序列进行系统发育分析,确定了它们出现的顺序。利用所有可获得的C6 - C9蛋白以及穿孔素的序列数据,结果表明这些TCC成分起源于一个单一的祖先基因,并且C6和C7是最早出现的。我们的证据支持这样一种观点,即祖先基因具有复杂的模块化组成。一系列基因复制与模块丢失的趋势相结合,导致了模块化复杂性逐渐降低的连续补体蛋白。C9和穿孔素显然是获得成孔功能的不同选择条件的结果。因此,C9和穿孔素是进化平行性的例子。

相似文献

1
Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.末端补体复合物同源蛋白的系统发育分析支持C6和C7先出现,随后是C8和C9。
J Mol Evol. 1999 Aug;49(2):282-9. doi: 10.1007/pl00006550.
2
Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.人补体C8整合到膜攻击复合物中是由位于C8βMACPF结构域内的一个结合位点介导的。
Mol Immunol. 2007 Feb;44(5):960-5. doi: 10.1016/j.molimm.2006.03.012. Epub 2006 Apr 19.
3
Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.人补体C8与C9的结合:C8α亚基中N端结构域的作用
Biochemistry. 2002 Dec 10;41(49):14546-51. doi: 10.1021/bi026641j.
4
Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.人类补体蛋白C8α的MACPF结构域的功能研究揭示了C8β、C8γ和C9同时结合的位点。
Biochemistry. 2006 Apr 25;45(16):5290-6. doi: 10.1021/bi0601860.
5
Structure of the human C7 gene and comparison with the C6, C8A, C8B, and C9 genes.人类C7基因的结构及其与C6、C8A、C8B和C9基因的比较。
J Immunol. 1995 May 15;154(10):5188-94.
6
Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.补体替代途径的成分和调节蛋白以及膜攻击复合物在正常和病变滑膜中的表达。
Rheumatol Int. 1993;13(4):139-46. doi: 10.1007/BF00301260.
7
Molecular cloning of the terminal complement components C6 and C8beta of cartilaginous fish.软骨鱼末端补体成分 C6 和 C8β的分子克隆。
Fish Shellfish Immunol. 2009 Dec;27(6):768-72. doi: 10.1016/j.fsi.2009.08.008. Epub 2009 Aug 27.
8
Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.人 C8 蛋白的结构为补体介导的膜孔形成提供了机制见解。
J Biol Chem. 2011 May 20;286(20):17585-92. doi: 10.1074/jbc.M111.219766. Epub 2011 Mar 25.
9
Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro.体外检测人脐静脉内皮细胞中终末补体成分C5、C6、C8和C9的mRNA。
APMIS. 2001 Jan;109(1):73-8. doi: 10.1111/j.1600-0463.2001.tb00016.x.
10
Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.人补体C8的C8α-γ亚基与C8β亚基之间的相互作用:C8β N端血小板反应蛋白1型模块和膜攻击复合物/穿孔素结构域的作用
Biochemistry. 2002 Sep 17;41(37):11255-60. doi: 10.1021/bi026207h.

引用本文的文献

1
Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity.猪C9补体成分与溶血补体活性的遗传关联。
Asian-Australas J Anim Sci. 2015 Sep;28(9):1354-61. doi: 10.5713/ajas.14.0734.
2
Perforin evolved from a gene duplication of MPEG1, followed by a complex pattern of gene gain and loss within Euteleostomi.穿孔素是由 MPEG1 基因复制进化而来,随后在真骨鱼类中经历了复杂的基因获得和丢失模式。
BMC Evol Biol. 2012 May 2;12:59. doi: 10.1186/1471-2148-12-59.
3
Molecular characterization of the alpha subunit of complement component C8 (GcC8alpha) in the nurse shark (Ginglymostoma cirratum).
护士鲨(Ginglymostoma cirratum)中补体成分C8(GcC8α)α亚基的分子特征分析
Fish Shellfish Immunol. 2009 Sep;27(3):397-406. doi: 10.1016/j.fsi.2009.05.020. Epub 2009 Jun 12.
4
Gene duplication of the seventh component of complement in rainbow trout.
Immunogenetics. 2005 Oct;57(9):703-8. doi: 10.1007/s00251-005-0028-7. Epub 2005 Oct 18.
5
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.通过被动转移抗VII型胶原蛋白特异性抗体诱导小鼠皮肤-表皮分离。
J Clin Invest. 2005 Apr;115(4):870-8. doi: 10.1172/JCI21386.
6
Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.补体与扩张型心肌病:心肌细胞中亚溶解末端补体复合物诱导肿瘤坏死因子-α合成的作用
Am J Pathol. 2002 Aug;161(2):449-57. doi: 10.1016/s0002-9440(10)64201-0.
7
Hepatocyte nuclear factor 1alpha controls the expression of terminal complement genes.肝细胞核因子1α调控末端补体基因的表达。
J Exp Med. 2001 Dec 3;194(11):1683-9. doi: 10.1084/jem.194.11.1683.